Neuraxis NRXS
NYSE NRXS
$6.15 -0.12 (-1.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neuraxis (NRXS) Shares Outstanding (2022 - 2026)

Neuraxis (NRXS) posted Shares Outstanding (Entity) of $11.5 million for Q1 2026, up 7.48% sequentially from $10.7 million in Q4 2025, and up 58.68% YoY from $7.2 million in Q1 2025.

Neuraxis (NRXS) Shares Outstanding (2022 - 2026) Analysis & Trends

Neuraxis has reported Shares Outstanding (Entity) for 5 years, with the latest figure at $11.5 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 58.68% year-over-year to $11.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (up 58.68% YoY) and the FY2025 annual result came in at $10.7 million, up 52.4% from the prior year.
  • Shares Outstanding (Entity) advanced to $11.5 million in Q1 2026 per NRXS's latest filing, from $10.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $11.5 million in Q1 2026 and troughed at $1.9 million in Q2 2022.
  • A 5-year average of $5.8 million and a median of $6.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) climbed 1.09% in 2023, then soared 248.47% in 2024.
  • Over 5 years, Shares Outstanding (Entity) stood at $2.0 million in 2022, then soared by 65.65% to $3.3 million in 2023, then jumped by 114.93% to $7.0 million in 2024, then jumped by 52.4% to $10.7 million in 2025, then grew by 7.48% to $11.5 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $11.5 million, $10.7 million, and $9.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 Neuraxis 74.54 Mn 66.21 Mn - 12.12 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 12.12 Mn
Mar 31, 2026 10.95 Mn
Dec 31, 2025 9.08 Mn
Sep 30, 2025 9.88 Mn
Jun 30, 2025 8.52 Mn
Mar 31, 2025 7.46 Mn
Dec 31, 2024 6.92 Mn
Sep 30, 2024 7.17 Mn
Jun 30, 2024 6.92 Mn
Mar 31, 2024 6.55 Mn
Dec 31, 2023 3.25 Mn
Sep 30, 2023 3.63 Mn
Jun 30, 2023 2.00 Mn
Mar 31, 2023 2.00 Mn
Dec 31, 2022 2.00 Mn
Sep 30, 2022 1.99 Mn
Jun 30, 2022 1.97 Mn